When a large global ingredient supplier puts its name behind a new postbiotic, it tells the market this category has moved past early-adopter status. Postbiotics have been gaining traction because they sidestep some of the stability and shelf-life headaches that live probiotics create, which makes them attractive for a wider range of formats: capsules, powders, functional foods, even beverages and patches. For brand owners, the real question isn't whether postbiotics are trending, it's whether your manufacturing partner can actually work with these newer ingredient classes at scale.
Postbiotic inputs often come with specific handling, dosing, and stability requirements that differ from traditional probiotic strains, and not every contract manufacturer has adapted their processes yet. Brands considering a postbiotic launch should ask early about compatibility with existing production lines, minimum order quantities from ingredient suppliers, and how claims will be substantiated for US and LATAM regulatory review. Partnering with a manufacturer that already tracks ingredient innovation and understands cross-border compliance saves time when deciding whether a new postbiotic is worth building a product around, or better left for a later product cycle.

